Cargando…

An automated dose verification software for brachytherapy

PURPOSE: To report an implementation method and the results of independent brachytherapy dose verification software (DVS). MATERIAL AND METHODS: The DVS was developed based on Visual C++ and adopted a modular structure design. The DICOM RT files exported from a treatment planning system (TPS) were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xianliang, Wang, Pei, Li, Churong, Wu, Zhangwen, Gou, Chengjun, Li, Jie, Kang, Shengwei, Hou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251445/
https://www.ncbi.nlm.nih.gov/pubmed/30479626
http://dx.doi.org/10.5114/jcb.2018.79396
_version_ 1783373124256923648
author Wang, Xianliang
Wang, Pei
Li, Churong
Wu, Zhangwen
Gou, Chengjun
Li, Jie
Kang, Shengwei
Hou, Qing
author_facet Wang, Xianliang
Wang, Pei
Li, Churong
Wu, Zhangwen
Gou, Chengjun
Li, Jie
Kang, Shengwei
Hou, Qing
author_sort Wang, Xianliang
collection PubMed
description PURPOSE: To report an implementation method and the results of independent brachytherapy dose verification software (DVS). MATERIAL AND METHODS: The DVS was developed based on Visual C++ and adopted a modular structure design. The DICOM RT files exported from a treatment planning system (TPS) were automatically loaded into the DVS. The DVS used the TG-43 formalism for dose calculation. A total of 15 cervical cancer patients who underwent brachytherapy were retrospectively selected to test the DVS. Dosimetric parameters and γ analysis (0.1 cm, 5%) were used to evaluate the dose differences between the DVS and the TPS. RESULTS: Compared with the TPS dose, the γ pass rates of the dose calculated by the DVS were higher than 98%. For the clinical target volume (CTV), the dosimetric differences were less than 0.63% for D(90%) and D(100%). For the bladder, rectum, and sigmoid, the agreement of D(0.1cc), D(1cc), and D(2cc) were within a 0.78% level. CONCLUSIONS: With minimal human-computer interactions, the DVS can verify the accuracy of doses calculated by the TPS.
format Online
Article
Text
id pubmed-6251445
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-62514452018-11-26 An automated dose verification software for brachytherapy Wang, Xianliang Wang, Pei Li, Churong Wu, Zhangwen Gou, Chengjun Li, Jie Kang, Shengwei Hou, Qing J Contemp Brachytherapy Original Paper PURPOSE: To report an implementation method and the results of independent brachytherapy dose verification software (DVS). MATERIAL AND METHODS: The DVS was developed based on Visual C++ and adopted a modular structure design. The DICOM RT files exported from a treatment planning system (TPS) were automatically loaded into the DVS. The DVS used the TG-43 formalism for dose calculation. A total of 15 cervical cancer patients who underwent brachytherapy were retrospectively selected to test the DVS. Dosimetric parameters and γ analysis (0.1 cm, 5%) were used to evaluate the dose differences between the DVS and the TPS. RESULTS: Compared with the TPS dose, the γ pass rates of the dose calculated by the DVS were higher than 98%. For the clinical target volume (CTV), the dosimetric differences were less than 0.63% for D(90%) and D(100%). For the bladder, rectum, and sigmoid, the agreement of D(0.1cc), D(1cc), and D(2cc) were within a 0.78% level. CONCLUSIONS: With minimal human-computer interactions, the DVS can verify the accuracy of doses calculated by the TPS. Termedia Publishing House 2018-10-31 2018-10 /pmc/articles/PMC6251445/ /pubmed/30479626 http://dx.doi.org/10.5114/jcb.2018.79396 Text en Copyright: © 2018 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle Original Paper
Wang, Xianliang
Wang, Pei
Li, Churong
Wu, Zhangwen
Gou, Chengjun
Li, Jie
Kang, Shengwei
Hou, Qing
An automated dose verification software for brachytherapy
title An automated dose verification software for brachytherapy
title_full An automated dose verification software for brachytherapy
title_fullStr An automated dose verification software for brachytherapy
title_full_unstemmed An automated dose verification software for brachytherapy
title_short An automated dose verification software for brachytherapy
title_sort automated dose verification software for brachytherapy
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6251445/
https://www.ncbi.nlm.nih.gov/pubmed/30479626
http://dx.doi.org/10.5114/jcb.2018.79396
work_keys_str_mv AT wangxianliang anautomateddoseverificationsoftwareforbrachytherapy
AT wangpei anautomateddoseverificationsoftwareforbrachytherapy
AT lichurong anautomateddoseverificationsoftwareforbrachytherapy
AT wuzhangwen anautomateddoseverificationsoftwareforbrachytherapy
AT gouchengjun anautomateddoseverificationsoftwareforbrachytherapy
AT lijie anautomateddoseverificationsoftwareforbrachytherapy
AT kangshengwei anautomateddoseverificationsoftwareforbrachytherapy
AT houqing anautomateddoseverificationsoftwareforbrachytherapy
AT wangxianliang automateddoseverificationsoftwareforbrachytherapy
AT wangpei automateddoseverificationsoftwareforbrachytherapy
AT lichurong automateddoseverificationsoftwareforbrachytherapy
AT wuzhangwen automateddoseverificationsoftwareforbrachytherapy
AT gouchengjun automateddoseverificationsoftwareforbrachytherapy
AT lijie automateddoseverificationsoftwareforbrachytherapy
AT kangshengwei automateddoseverificationsoftwareforbrachytherapy
AT houqing automateddoseverificationsoftwareforbrachytherapy